Navigation Links
Med Ad News Magazine Announces Nominees for the 22nd Annual Manny Awards as Well as Advertising Person of the Year
Date:3/25/2011

lsonTaylor: Dexilant
  • Cambridge BioMarketing: CAution Campaign
  • Draftfcb Healthcare: Merck - Hypoglycemia

  • Best Interactive Patient Campaign:

    • Digitas Health: I Pick My Nose
    • Euro RSCG Life 4D: ShareYourPain.com
    • Ogilvy CommonHealth Worldwide: BayerForWomen.com

    Best Interactive Physician Campaign:

    • AgencyRx LLC: Iron Overload
    • Draftfcb Healthcare: Cephalon Oncology
    • GSW Worldwide: Lilly Diabetes

    Heart Award:

    • CDM New York
    • Havas Worldwide Health
    • Siren Interactive

    Vision Award:

    • CAHG
    • Euro RSCG Life 4D
    • Strikeforce Communications LLC

    Med Ad News congratulates Advertising Person of the Year Matt Giegerich and all award nominees.

    The 22nd Annual Manny Awards celebration on Thursday, April 28, 2011, at Sheraton New York Hotel and Towers in New York, N.Y., will begin with a cocktail hour at 6:30 p.m. and continue with a sit-down dinner at 7:30 p.m. The awards ceremony will commence at 8:30 p.m. Black tie is optional.

    For reservations, contact:

    Francine Stone at (215) 944-9827 or Francine.Stone@ubm.com or visit www.mannyawards.com

    For sponsorship opportunities, contact:

    Patricia Spinner at (973) 808-1250 or Patricia.Spinner@ubm.com

    Daniel Becker at (973) 808-1191 or Daniel.Becker@ubm.com

    About the Manny Awards

    For more than 20 years, the Med Ad News Manny Awards have paid tribute to the creative work of agencies serving the healthcare market, their people, and their contributions to the industry. Each yea
    '/>"/>

    SOURCE Med Ad News
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Sutter Health Among the Nations Top Employers According to Readers of CAREERS & the disABLED Magazine
    2. CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing
    3. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
    4. Business-to-Business Magazine Names Orion HealthCorp CEO as Top 25 Entrepreneur for 2010
    5. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
    6. CardioGenics Featured on Cover of Medical Device & Diagnostic Industry Magazine
    7. Microfluidic Systems (MFSI) Receives Award from Inc. Magazine
    8. Abbott Honored for Workplace Leadership for the Tenth Consecutive Year by Working Mother Magazine
    9. Diplomat Specialty Pharmacy Honored by Inc. Magazine as One of the Nations Fastest-Growing Companies
    10. Atrium Recognized by Business NH Magazine
    11. Inc. Magazine Unveils 29th Annual List of Americas Fastest-Growing Private Companies—the Inc. 500
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/31/2014)... , Oct. 31, 2014  Zebra Imaging, ... visualization technologies announced today a strategic partnership with ... in high-end 3D anatomy and biomedical models for ... and medical education markets.  Zygote maintains the world,s ... biomedical models and has pioneered development of high-end ...
    (Date:10/31/2014)... JERUSALEM , October 31, 2014 ... ), a clinical-stage pharmaceutical company focused on the ... the company will host a conference call to ... clinical trial of ORMD-0801, the company,s proprietary oral ... Monday, November 3, 2014 at 10:00 a.m. Eastern ...
    (Date:10/31/2014)... 31, 2014  Zacks.com announces the list of stocks featured in ... the latest news and events impacting stocks and the financial markets. ... AMGN - Free Report ), Celgene (Nasdaq: CELG ... - Free Report ), Market Vectors Biotech ETF (AMEX: ... ETF (AMEX: XBI - Free Report ). ...
    Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
    ... Oritavancin Studies Presented at ECCMID/ICC, MUNICH, Germany, ... announced results from two studies showing the,improved ... in vitro,when tested with a common wetting ... activity of oritavancin against S.,pneumoniae in a ...
    ... 04, 2007 /PRNewswire-FirstCall/ -- Celgene,Corporation announced that ... that its Data Monitoring Committee's (DMC),review of ... for patients with newly diagnosed multiple myeloma ... dose of dexamethasone (Decadron) in,combination with lenalidomide ...
    Cached Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7
    (Date:10/31/2014)... Santa Barbara, CA (PRWEB) October 31, 2014 ... for holiday shoppers to find affordable but tasteful gifts for ... special 22nd Annual Early Bird Gift Giving Special , ... percent off when they purchase Wine Club Gift membership. ... to take advantage of this special. Besides offering discounts, Gold ...
    (Date:10/31/2014)... 2014 The Suspension Revolution review published ... was developed by Dan Long, a suspension training specialist. ... fitness professional and life coach. The author of this ... muscles is not impossible , The Suspension Revolution review ... Suspension training promises efficiency when it comes to burning ...
    (Date:10/31/2014)... October 31, 2014 North Shore Eye ... Garden City, Long Island and the addition of leading ... staff, according to North Shore Eye Care Medical Director, ... Acting Chairman of the Department of Ophthalmology of Winthrop-University ... in Garden City for more than 30 years. He ...
    (Date:10/31/2014)... Beach, Florida (PRWEB) October 31, 2014 ... or, the “Company”) today announced it has signed a ... Canada-based companies in the urban cultivation sector - Urban ... (BC Northern Lights”), and W3 Metal Inc. (“W3 Metal” ... the “Target Companies”). Pursuant to the LOI and ...
    (Date:10/31/2014)... RESEARCH UK scientists have found a drug combination that ... - paving the way for new treatments, according to ... Research Institute (NCRI) Cancer Conference in Liverpool next week*. ... initiate a chain of events culminating in self destruction. ... and become immortal. This means that cells grow out ...
    Breaking Medicine News(10 mins):Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Scientists trigger self-destruct switch in lung cancer cells 2
    ... cancer of the eye need not have to remove their ... The results of the Collaborative ocular Melanoma ... found that survival rates were the same regardless of whether ... radiation therapy.// , Davidorf, Professor ...
    ... affects women in their 30s and 40s, especially women.The illness ... cause pain, inflammation and joint destruction. , ... condition, but one third of the patients discontinue treatment early ... taking Methotrexate are prone for their drug-related liver damage .This ...
    ... exercise can improve their health or it would not make a ... Consensus statements published by the American College of ... researchers often can't tell how much health-improvement pay-off will result from ... make a difference at all. , , ...
    ... levels is becoming an increasingly important part of a medical ... or 'good' cholesterol) levels should be high, and low density ... At Johns Hopkins ... to measure non-HDL cholesterol too. This is the difference between ...
    ... to kill the deadly Hepatitis E virus has been designed by ... would kill the virus by cutting RNA. , , ... animals. The cloned virus could also be used for diagnostic purposes ... For this, the team had produced ...
    ... in tomato products, such as tomato sauce and ketchup, have ... especially prostate cancer, but the reason for such an action ... that lycopene, which is found in tomato products and other ... and treating the disease in its earliest stages.// ...
    Cached Medicine News:Health News:How much can exercise improve health? 2Health News:Protective effects of tomatoes in prostate cancer 2
    A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
    ... L.E.D. is mounted coaxially on the loupe ... battery pack giving 4 hours continuous use. ... and a charging unit that can hold ... as being a convenient container to keep ...
    The PDM utilizes the latest technology for measuring interpupillary distance and left/right pupil-to-nose distance. Lightweight and easy-to-use, the PDM provides accurate and repeatable PD measuremen...
    Inquire...
    Medicine Products: